Noriko Gotoh

9.6k citations

116 papers · 6.4k indexed · 1 hit paper · h-index 39

Impact in

Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Molecular Biology top 1%
- Extracellular vesicles in disease
- Fibroblast Growth Factor Research
- RNA Interference and Gene Delivery
- Protein Kinase Regulation and GTPase Signaling
- Circular RNAs in diseases
- Epigenetics and DNA Methylation

Papers in

Cancer Research 27
- Cancer, Hypoxia, and Metabolism 11
Oncology 43
- Cancer Cells and Metastasis 19
- HER2/EGFR in Cancer Research 11
- Cytokine Signaling Pathways and Interactions 9

Co-authors: Joseph Schlessinger Irit Lax Yaron R. Hadari Masahiko Kuroda Takayuki Mizutani Shin‐ichiro Ohno Takahiro Ochiya Masakatsu Takanashi
Journals: Cancer Science (8 papers)Biochemical and Biophysical Research Communications (8 papers)Proceedings of the National Academy of Sciences (7 papers)Oncogene (6 papers)Scientific Reports (5 papers)
Partner nations: Japan United States Brazil

In The Last Decade

Noriko Gotoh

113 papers receiving 6.3k citations

Hit Papers

align trajectories log scale

Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells 2012 · 1.4k citations

Peers

Countries citing papers authored by Noriko Gotoh

Since Specialization

Citations

This map shows the geographic impact of Noriko Gotoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noriko Gotoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noriko Gotoh more than expected).

Fields of papers citing papers by Noriko Gotoh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noriko Gotoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noriko Gotoh. The network helps show where Noriko Gotoh may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Noriko Gotoh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Noriko Gotoh Line = papers co-authored together Noriko Gotoh links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Permeable Lung Vasculature Creates Chemoresistant Endothelial Niche by Producing SERPINE1 at Breast Cancer Metastatic Sites Cancer Science ·Tsunaki Hongu, 爱华任, Eui-young Kim, О. І. Маловічко, Akihiko Ishimura, Danielle Nascimento Silva, Thórdur Óskarsson, Noriko Gotoh	2025	1
2	Revealing neuropilin expression patterns in pancreatic cancer: From single‑cell to therapeutic opportunities (Review) Oncology Letters ·Karen Karvonen, Tomoaki Hara, Hiromichi Sato, Zühal KALCIOĞLU, Z.G. Huseynov, Yoshiko Saito, Sherman K. Grinnell, D. Ganesh, Noriko Gotoh, Kazuhiko Ogawa, Hideshi Ishii	2024	2
3	RNA binding protein ZCCHC24 promotes tumorigenicity in triple-negative breast cancer EMBO Reports ·Y. UCHIDA, Ryota Kurimoto, Tomoki Chiba, Takahide Matsushima, Goshi Oda, Iichiroh Onishi, Yasuto Takeuchi, Noriko Gotoh, Hiroshi Asahara	2024	1
4	Tolerable glycometabolic stress boosts cancer cell resilience through altered N-glycosylation and Notch signaling activation Cell Death and Disease ·真吾上田, Takashi Kobayashi, Hisatoshi Hanamatsu, Ziyun Ruan, Orsolya Endrődy, 敏康古田, K Bradberry, Arvin Clark Opiniano Salinas, 安蒜聡, Annalisa Petrilli, Mohammed Baradwan, L Imtinaro, Ryo Ushioda, Kazuhiro Nagata, Noriko Gotoh, Kazuki Nakajima, Takashi Nishikaze, Jun‐ichi Furukawa, Naoki Itano	2024	5
5	Inflammatory cytokine‐enriched microenvironment plays key roles in the development of breast cancers Cancer Science ·Yasuto Takeuchi, Noriko Gotoh	2023	5
6	Mint3-depletion-induced energy stress sensitizes triple-negative breast cancer to chemotherapy via HSF1 inactivation Cell Death and Disease ·Noritaka Tanaka, Hikari Okada, Kiyoshi Yamaguchi, Masahide Seki, Daisuke Matsubara, Noriko Gotoh, Yutaka Suzuki, Yoichi Furukawa, Taro Yamashita, Jun‐ichiro Inoue, Shuichi Kaneko, Takeharu Sakamoto	2023	5
7	Inhibition of the mitochondria-shaping protein Opa1 restores sensitivity to Gefitinib in a lung adenocarcinomaresistant cell line Cell Death and Disease ·Chao Xie, Susumu Kohno, Anna Pellattiero, Kauser J Khawja, Keitaro Shibata, Norihito Shintani, Takashi Kohno, Noriko Gotoh, Chiaki Takahashi, Atsushi Hirao, Luca Scorrano, Atsuko Kasahara	2023	24
8	Efp promotes growth of triple-negative breast cancer cells Biochemical and Biophysical Research Communications ·Wataru Sato, Kazuhiro Ikeda, Noriko Gotoh, Satoshi Inoue, Kuniko Horie	2022	4
9	A novel oral inhibitor for one-carbon metabolism and checkpoint kinase 1 inhibitor as a rational combination treatment for breast cancer Biochemical and Biophysical Research Communications ·Jin Lee, Xiaoxi Chen, Yuming Wang, Tatsunori Nishimura, Mengjiao Li, Satoko Ishikawa, Takiko Daikoku, Junya Kawai, Arinobu Tojo, Noriko Gotoh	2021	5
10	MUSASHI‐2 confers resistance to third‐generation EGFR‐tyrosine kinase inhibitor osimertinib in lung adenocarcinoma Cancer Science ·Denise Tonetta, Yasuto Takeuchi, Tatsunori Nishimura, Mengjiao Li, Yu‐Ming Wang, Makiko Meguro‐Horike, Takashi Kohno, Shin‐ichi Horike, Asuka Nakata, Noriko Gotoh	2021	13
11	Cytoplasmic DNA accumulation preferentially triggers cell death of myeloid leukemia cells by interacting with intracellular DNA sensing pathway Cell Death and Disease ·Tomohisa Baba, Takeshi Yoshida, Bramhall Js, Tatsunori Nishimura, Soji Morishita, Noriko Gotoh, Atsushi Hirao, Rikinari Hanayama, Naofumi Mukaida	2021	14
12	Mint3 depletion restricts tumor malignancy of pancreatic cancer cells by decreasing SKP2 expression via HIF-1 Oncogene ·Jensen Ah, Daisuke Matsubara, Yurika Saitoh, Aaron Spurling, Noriko Gotoh, Shuichi Kaneko, Motoharu Seiki, Yoshinori Murakami, Jun‐ichiro Inoue, Takeharu Sakamoto	2020	19
13	Upregulation of S100A10 in metastasized breast cancer stem cells Cancer Science ·O. Ohwo, Takashi Watanabe, Tatsunori Nishimura, Takanori Hayashi, Seishi Kono, Hitomi Tsuchida, Munetsugu Hirata, Yuko Kijima, Shintaro Takao, Seiji Okada, Motoshi Suzuki, Kazuyoshi Imaizumi, Kenji Kawada, Hironobu Minami, Noriko Gotoh, Yohei Shimono	2020	22
14	Patient-Derived Xenograft Models of Breast Cancer and Their Application Cells ·Takahiko Murayama, Noriko Gotoh	2019	98
15	A Novel Serum 4-microRNA Signature for Lung Cancer Detection Scientific Reports ·Ernest Nadal, Anna Truini, Asuka Nakata, Jules Lin, Rishindra M. Reddy, Andrew C. Chang, Nithya Ramnath, Noriko Gotoh, David G. Beer, Guoan Chen	2015	108
16	Pyruvate kinase M2, but not M1, allele maintains immature metabolic states of murine embryonic stem cells Regenerative Therapy ·Masamitsu Konno, J. Adjaye, Jun Koseki, Nobuhiro Tanuma, Naohiro Nishida, Koichi Kawamoto, Tatsunori Nishimura, Asuka Nakata, Hidetoshi Matsui, Inès Vanbinst, Miyuki Ozaki, Yuko Noguchi, Hiroshi Shima, Noriko Gotoh, Hiroaki Nagano, Yuichiro� Doki, Masaki Mori	2015	6
17	Gene set enrichment analysis provides insight into novel signalling pathways in breast cancer stem cells British Journal of Cancer ·Michiko Murohashi, Kunihiko Hinohara, Masahiko Kuroda, Takayuki Isagawa, Shingo Tsuji, S Kobayashi, Kazuo Umezawa, Arinobu Tojo, Hiroyuki Aburatani, Noriko Gotoh	2009	74
18	FRS2 family docking proteins with overlapping roles in activation of MAP kinase have distinct spatial‐temporal patterns of expression of their transcripts FEBS Letters ·Noriko Gotoh, Shaked Laks, Misako Nakashima, Irit Lax, Joseph Schlessinger	2004	60
19	Shc Regulates Epidermal Growth Factor-induced Activation of the JNK Signaling Pathway Journal of Biological Chemistry ·Ari Hashimoto, Mari Kurosaki, Noriko Gotoh, Masabumi Shibuya, Tomohiro Kurosaki	1999	51
20	Tyrosine Phosphorylation Sites at Amino Acids 239 and 240 of Shc Are Involved in Epidermal Growth Factor-Induced Mitogenic Signaling That Is Distinct from Ras/Mitogen-Activated Protein Kinase Activation Molecular and Cellular Biology ·Noriko Gotoh, Masashi Toyoda, Yinhu	1997	138

About Noriko Gotoh

Noriko Gotoh is a scholar working on Cancer Research, Oncology, Molecular Biology, Cell Biology and Ophthalmology, having authored 116 papers that have together received 6.4k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (19 papers), Fibroblast Growth Factor Research (17 papers), Protein Kinase Regulation and GTPase Signaling (12 papers), HER2/EGFR in Cancer Research (11 papers), Cancer, Hypoxia, and Metabolism (11 papers), Lung Cancer Treatments and Mutations (10 papers), Cytokine Signaling Pathways and Interactions (9 papers) and Wnt/β-catenin signaling in development and cancer (8 papers). The work is most often cited by research in Cancer Research (1.9k citations), Molecular Biology (5.0k citations), Oncology (1.3k citations), Cell Biology (717 citations) and Immunology and Allergy (263 citations). Noriko Gotoh has collaborated with scholars based in Japan, United States and Brazil. Frequent co-authors include Joseph Schlessinger, Irit Lax, Yaron R. Hadari, Masahiko Kuroda, Takayuki Mizutani, Shin‐ichiro Ohno, Takahiro Ochiya, Masakatsu Takanashi, Nagahisa Matsuyama and Shinobu Ueda. Their work appears in journals such as Cancer Science, Biochemical and Biophysical Research Communications, Proceedings of the National Academy of Sciences, Oncogene and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact